Azza Khalil

6PUBLICATIONS
27CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 18, 2025
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.

Tine Schytte, Marianne M Knap, Charlotte Kristiansen

|Feb 18, 2022
Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital.

Signe Sørup, Bianka Darvalics, Jakob Schöllhammer Knudsen

|Sep 30, 2021
Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation.

Signe Sørup, Bianka Darvalics, Azza Ahmed Khalil

|Feb 01, 2021
A comparison of two methods for segmentation of functional volumes in radiotherapy planning of lung cancer patients.

T B Nyeng, D S Møller, K Farr

|Dec 06, 2017
Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT.

M Kandi, L Hoffmann, D Sloth Moeller

|Aug 24, 2017
The NARLAL2 dose escalation trial: dosimetric implications of inter-fractional changes in organs at risk.

Lone Hoffmann, Marianne Marquard Knap, Azza Ahmed Khalil

Pageof 1

Frequent Collaborators

4 joint publications

Lone Hoffmann

2 joint publications

Marianne Marquard Knap

2 joint publications

Signe Sørup

2 joint publications

Bianka Darvalics